JP2000506128A - 抗病原性ペプチドおよびこれらを含む組成物 - Google Patents

抗病原性ペプチドおよびこれらを含む組成物

Info

Publication number
JP2000506128A
JP2000506128A JP9529954A JP52995497A JP2000506128A JP 2000506128 A JP2000506128 A JP 2000506128A JP 9529954 A JP9529954 A JP 9529954A JP 52995497 A JP52995497 A JP 52995497A JP 2000506128 A JP2000506128 A JP 2000506128A
Authority
JP
Japan
Prior art keywords
peptide
amino acid
peptides
cytolytic
hemolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP9529954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000506128A5 (enExample
Inventor
シャイ，イエチェル
オレン，ズイブ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of JP2000506128A publication Critical patent/JP2000506128A/ja
Publication of JP2000506128A5 publication Critical patent/JP2000506128A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP9529954A 1996-02-22 1997-02-20 抗病原性ペプチドおよびこれらを含む組成物 Ceased JP2000506128A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL117223 1996-02-22
IL11722396A IL117223A0 (en) 1996-02-22 1996-02-22 Antipathogenic polypeptides and compositions comprising them
PCT/IL1997/000066 WO1997031019A2 (en) 1996-02-22 1997-02-20 Antipathogenic peptides and compositions comprising them

Publications (2)

Publication Number Publication Date
JP2000506128A true JP2000506128A (ja) 2000-05-23
JP2000506128A5 JP2000506128A5 (enExample) 2004-11-11

Family

ID=11068576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9529954A Ceased JP2000506128A (ja) 1996-02-22 1997-02-20 抗病原性ペプチドおよびこれらを含む組成物

Country Status (13)

Country Link
US (1) US6172038B1 (enExample)
EP (1) EP0904291A2 (enExample)
JP (1) JP2000506128A (enExample)
KR (2) KR19990087100A (enExample)
CN (1) CN1216549A (enExample)
AU (1) AU730069B2 (enExample)
BR (1) BR9707691A (enExample)
CA (1) CA2247025A1 (enExample)
CZ (1) CZ264398A3 (enExample)
EA (1) EA199800754A1 (enExample)
IL (2) IL117223A0 (enExample)
NZ (1) NZ331219A (enExample)
WO (1) WO1997031019A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014059252A (ja) * 2012-09-19 2014-04-03 Milbon Co Ltd スクリーニング方法

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9807456A (pt) * 1997-02-20 2000-04-25 Yeda Res & Dev Peptìdios antipatogênicos sintéticos e composições que compreendem os mesmos
BR9912053A (pt) 1998-07-13 2001-04-03 Univ Texas Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
ATE348163T1 (de) 1998-10-23 2007-01-15 Amgen Inc Thrombopoietin substitute
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
IL139720A0 (en) * 2000-11-16 2002-02-10 Yeda Res & Dev Diastereomeric peptides and pharmaceutical compositions comprising them
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
EP1773400A2 (en) 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
CA2580796C (en) 2004-09-24 2013-03-26 Amgen Inc. Modified fc molecules having peptides inserted in internal loop regions
CN101291683B (zh) * 2004-11-24 2011-08-17 纽普罗研究有限公司 治疗疾病的方法和组合物
WO2006128289A1 (en) * 2005-06-02 2006-12-07 University Of Manitoba Use of brevinin-2r in the treatment of cancer
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
EP1973556A2 (en) * 2005-12-27 2008-10-01 Yeda Research And Development Co., Ltd. Histidine-containing diastereomeric peptides and uses thereof
JP2009526046A (ja) 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2014038004A1 (ja) * 2012-09-05 2014-03-13 株式会社メニコン 薬物徐放性眼用レンズ及びその製造方法
WO2017134661A1 (en) 2016-02-04 2017-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
GB2557654A (en) * 2016-12-14 2018-06-27 Uea Enterprises Ltd Method for nucleic acid depletion
CN113528600A (zh) * 2021-07-08 2021-10-22 石河子大学 一种利用沙门氏菌诱导蝇蛆制备抗菌肽的方法
CN119607173B (zh) * 2025-01-07 2026-05-26 天津医科大学朱宪彝纪念医院(天津医科大学代谢病医院、天津代谢病防治中心) 小分子肽lklkll在制备降血糖产品中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258454A (en) * 1988-09-01 1993-11-02 Riso National Laboratory Peptide synthesis method and solid support for use in the method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014059252A (ja) * 2012-09-19 2014-04-03 Milbon Co Ltd スクリーニング方法

Also Published As

Publication number Publication date
AU730069B2 (en) 2001-02-22
EP0904291A2 (en) 1999-03-31
WO1997031019A3 (en) 1997-10-23
NZ331219A (en) 2000-04-28
CZ264398A3 (cs) 1999-01-13
IL117223A0 (en) 1996-06-18
KR19990087100A (ko) 1999-12-15
CA2247025A1 (en) 1997-08-28
IL125734A (en) 2005-08-31
WO1997031019A2 (en) 1997-08-28
IL125734A0 (en) 1999-04-11
US6172038B1 (en) 2001-01-09
EA199800754A1 (ru) 1999-10-28
BR9707691A (pt) 1999-07-27
AU1731997A (en) 1997-09-10
CN1216549A (zh) 1999-05-12
KR20000071187A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
US7001983B1 (en) Antipathogenic synthetic peptides and compositions comprising them
US6172038B1 (en) Antipathogenic peptides and compositions comprising them
Oren et al. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure− function study
KR100891157B1 (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
Hong et al. Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes
KR101345333B1 (ko) 라이신 및 트립토판 잔기가 ４번 반복된 신규한 항균 및 항진균 펩타이드 및 이의 용도
JPH09509175A (ja) 広域スペクトル抗菌化合物と使用方法
JP2008537537A (ja) 抗微生物ヘキサペプチド
JP2002523517A (ja) 生物活性ペプチド
JPH05504566A (ja) 生物学的活性を有するペプチドを使用した創傷処置方法
US9079937B2 (en) Dendrimeric peptides, pharmaceutical compositions and methods of using the same
André et al. Structure–activity relationship-based optimization of small temporin-SHf analogs with potent antibacterial activity
KR20070102677A (ko) 용혈현상이 감소된 항균성 펩티드 및 그들의 사용방법
Andrä et al. Shortened amoebapore analogs with enhanced antibacterial and cytolytic activity
US7745390B2 (en) Antimicrobial peptides
Kuhn-Nentwig et al. Cupiennin 1d*: the cytolytic activity depends on the hydrophobic N-terminus and is modulated by the polar C-terminus
Won et al. Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea
JPH0730120B2 (ja) 抗バクテリア・抗マラリア性ペプタイド
FR2823754A1 (fr) Peptides antibacteriens, les compositions les contenant et leurs utilisations
MXPA99007799A (en) Antipathogenic synthetic peptides and compositions comprising them
CZ293599A3 (cs) Nehemolytické cytolytické činidlo, peptid, cyklický peptid, cyklický derivát nepřírodního syntetického peptidu, Leu/Lys diastereomer, komplex provázaných peptidů, směs, nehemolytický cytolytický neuspořádaný kopolymer a farmaceutický prostředek
MXPA98006869A (en) Antipathogenic peptides and compositions that buy them
WO2001010887A2 (en) Multi-functional antimicrobial peptides
EP1507799A2 (fr) Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.
JPH0390099A (ja) トキソプラズマ増殖抑制剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071127

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20080501

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080617